Curtis Advisory Group, LLC Pfizer Inc Transaction History

Curtis Advisory Group, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 30, 2023	SELL	$41.75 - $54.5 $16,700 - $21,800	-400 Reduced 7.69%	4,800 $246,000
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $17,985 - $21,955	-411 Reduced 7.32%	5,200 $228,000
Q3 2021 Nov 12, 2021	BUY	$39.25 - $50.42 $4,356 - $5,596	111 Added 2.02%	5,611 $241,000
Q2 2021 Jul 27, 2021	BUY	$35.91 - $40.68 $197,504 - $223,740	5,500 New	5,500 $215,000

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Curtis Advisory Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Curtis Advisory Group, LLC with notifications on news.